Current diagnosis and management of symptomatic intracranial atherosclerotic disease

Current Opinion in Neurology

Volumn 25, Issue 1, 2012, Pages 18-26

  Prabhakaran, Shyam ^a   Romano, Jose G ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

intracranial atherosclerosis; intracranial stenting; stroke; stroke cause; stroke therapy

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; NADROPARIN; WARFARIN;

ANGIOPLASTY; ANTICOAGULANT THERAPY; BLEEDING; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIAGNOSTIC IMAGING; DIGITAL SUBTRACTION ANGIOGRAPHY; DOPPLER ECHOGRAPHY; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; REVIEW; RISK ASSESSMENT; RISK FACTOR; STENT; STROKE; TRANSIENT ISCHEMIC ATTACK;

BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; CONSTRICTION, PATHOLOGIC; DISEASE MANAGEMENT; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; NEUROIMAGING; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY;

EID: 84855711585     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0b013e32834ec16b     Document Type: Review

References (72)

1. Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995; 26:14-20.
2. Suri MF, Johnston SC. Epidemiology of intracranial stenosis. J Neuroimag 2009; 19 (Suppl. 1):11S-16S.
3. Wong LK. Global burden of intracranial atherosclerosis. Int J Stroke 2006; 1:158-159. (Pubitemid 44151508)
4. Gorelick PB, Wong KS, Bae H-J, Pandey DK. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke 2008; 39:2396-2399.
5. Lopez-Cancio E, Dorado L, Millan L, et al. Final results of the Barcelona-ASymptomatic Intracranial Atherosclerosis (ASIA) Study: prevalence and risk factors. Stroke 2011; 42:e87-e88.
6. Famakin BM, Chimowitz MI, Lynn MJ, et al. Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis. Stroke 2009; 40:1999-2003.
7. Cloft HJ, Joseph GJ, Dion JE. Risk of cerebral angiography in patients with subarachnoid hemorrhage, cerebral aneurysm, and arteriovenous malformation: a meta-analysis. Stroke 1999; 30:317-320. (Pubitemid 29071796)
8. Cloft HJ, Lynn MJ, Feldmann E, Chimowitz M. Risk of cerebral angiography in patients with symptomatic intracranial atherosclerotic stenosis. Cerebrovasc Dis 2011; 31:588-591.
9. Roubec M, Kuliha M, Jonszta T, et al. Detection of intracranial arterial stenosis using transcranial color-coded duplex sonography, computed tomographic angiography, and digital subtraction angiography. J Ultrasound Med 2011; 30:1069-1075.
10. Feldmann E, Wilterdink JL, Kosinski A, et al. The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology 2007; 68:2099-2106. (Pubitemid 46915385)
11. Martinelli O, Benedetti-Valentini F. Trancranial Doppler: value in clinical practice. Int Angiol 2009; 28:249-253.
12. Zhao L, Barlinn K, Sharma VK, et al. Velocity criteria for intracranial stenosis revisited: an international multicenter study of transcranial Doppler and digital subtraction angiography. Stroke 2011; 42:1-6.
13. Choi CG, Lee DH, Lee JH, et al. Detection of intracranial atherosclerotic steno-occlusive disease with 3D time-of-flight magnetic resonance angiography with sensitivity encoding at 3T. AJNR Am J Neuroradiol 2007; 28:439-446. (Pubitemid 46481879)
14. Sadikin C, Teng MM, Chen TY, et al. The current role of 1.5T noncontrast 3D time-of-flight magnetic resonance angiography to detect intracranial stenoocclusive disease. J Formos Med Assoc 2007; 106:691-699. (Pubitemid 47577635)
15. Bash S, Villablanca JP, Jahan R, et al. Intracranial vascular stenosis and occlusive disease: evaluation with CT angiography, MR angiography, and digital subtraction angiography. AJNR Am J Neuroradiol 2005; 26:1012-1021. (Pubitemid 43821943)
16. Willinek WA, von Falkenhausen M, Born M, et al. Noninvasive detection of steno-occlusive disease of the supra-aortic arteries with three-dimensional contrast-enhanced magnetic resonance angiography: a prospective, intraindividual comparative analysis with digital subtraction angiography. Stroke 2005; 36:38-43. (Pubitemid 40054172)
17. Wright VL, Olan W, Dick B, et al. Assessment of CE-MRA for the rapid detection of supra-aortic vascular disease. Neurology 2005; 65:27-32. (Pubitemid 40967772)
18. Amin-Hanjani S, Du X, Zhao M, et al. Use of quantitative magnetic resonance angiography to stratify stroke risk in symptomatic vertebrobasilar disease. Stroke 2005; 36:1140-1145. (Pubitemid 40798729)
19. Amin-Hanjani S, Alaraj A, Calderon-Arnulphi M, et al. Detection of intracranial in-stent restenosis using quantitative magnetic resonance angiography. Stroke 2011; 41:2534-2538.
20. Prabhakaran S, Warrior L, Wells KR, et al. The utility of quantitative magnetic resonance angiography in the assessment of intracranial in-stent stenosis. Stroke 2009; 40:991-993.
21. Degnan AJ, Gallagher G, Teng Z, et al. MR angiography and imaging for the evaluation of middle cerebral artery atherosclerotic disease. AJNR Am J Neuroradiol 2011. [Epub ahead of print]
22. Turan TN, Bonilha L, Morgan PS, et al. Intraplaque hemorrhage in symptomatic intracranial atherosclerotic disease. J Neuroimaging 2011; 21:159-161.
23. Katz DA, Marks MP, Napel SA, et al. Circle of Willis: evaluation with spiral CT angiography, MR angiography, and conventional angiography. Radiology 1995; 195:445-449.
24. Nguyen-Huynh MN, Wintermark M, English J, et al. How accurate is CT angiography in evaluating intracranial atherosclerotic disease? Stroke 2008; 39:1184-1188. (Pubitemid 351440689)
25. Caplan LR, Hennerici M. Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol 1998; 55:1475-1482. (Pubitemid 28525511)
26. Derdeyn CP, Powers WJ, Grubb RL. Hemodynamic effects of middle cerebral artery stenosis and occlusion. AJNR Am J Neuroradiol 1998; 19:1463-1469. (Pubitemid 30431039)
27. Wong KS, Gao S, Chan YL, et al. Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis: a diffusion-weighted imaging and microemboli monitoring study. Ann Neurol 2002; 52:74-81. (Pubitemid 34693746)
28. Wong KS, Li H, Lam WWM, et al. Progression of middle cerebral artery occlusive disease and its relationship with further vascular events after stroke. Stroke 2002; 33:532-536. (Pubitemid 34123401)
29. Zhao M, Charbel FT, Alperin N, et al. Improved phase-contrast flow quantification by three-dimensional vessel localization. Magn Reson Imaging 2000; 18:697-706. (Pubitemid 30626359)
30. Arenillas JF, Molina CA, Montaner J, et al. Progression and clinical recurrence of symptomatic middle cerebral artery stenosis: a long-term follow-up transcranial Doppler ultrasound study. Stroke 2001; 32:2898-2904. (Pubitemid 33134487)
31. Kwon SU, Hong KS, Kang DW, et al. Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis. Stroke 2011; 42:2883-2890.
32. Gao S, Wong KS, Hansberg T, et al. Microembolic signal predicts recurrent cerebral ischemic events in acute stroke patients with middle cerebral artery stenosis. Stroke 2004; 35:2832-2836. (Pubitemid 39565179)
33. Markus HS, Droste DW, Brown MM. Detection of asymptomatic cerebral embolic signals with Doppler ultrasound. Lancet 1994; 343:1011-1012. (Pubitemid 24122611)
34. Segura T, Serena J, Castellanos M, et al. Embolism in acute middle cerebral artery stenosis. Neurology 2001; 56:497-501. (Pubitemid 32172875)
35. Derdeyn CP, Grubb RL, Powers WJ. Cerebral hemodynamic impairment: methods of measurement and association with stroke risk. Neurology 1999; 53:251-259. (Pubitemid 29344343)
36. Silvestrini M, Vernieri F, Pasqualetti P, et al. Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. JAMA 2000; 283:2122-2127. (Pubitemid 30241308)
37. Liebeskind DS, Cotsonis GA, Saver JL, et al. Collateral circulation in symptomatic intracranial atherosclerosis. J Cereb Blood Flow Metab 2011; 31:1293-1301.
38. Liebeskind DS, Cotsonis GA, Saver JL, et al. Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol 2011; 69:963-974.
39. Uzunca I, Asil T, Balci K, Utku U. Evaluation of vasomotor reactivity by transcranial Doppler sonography in patients with acute stroke who have symptomatic intracranial and extracranial stenosis. J Ultrasound Med 2007; 26:179-185. (Pubitemid 46193337)
40. Lee JY, Lee YS. Vasomotor reactivity in middle cerebral artery stenosis. J Neurol Sci 2011; 301:35-37.
41. Ogasawara K, Ogawa A, Yoshimoto T. Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study. Stroke 2002; 33:1857-1862. (Pubitemid 34761076)
42. Kuroda S, Houkin K, Kamiyama H, et al. Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke 2001; 32:2110-2116.
43. Kidwell C, Alger JR, Saver J. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 2003; 34:2729-2735. (Pubitemid 37392775)
44. Konstas AA, Wintermark M, Lev MH. CT perfusion imaging in acute stroke. Neuroimaging Clin North Am 2011; 21:215-238; ix.
45. Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011; 365:993-1003.
46. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005; 352:1305-1316.
47. Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006; 113:555-563.
48. Turan TN, Maidan L, Cotsonis G, et al. Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke 2009; 40:505-509.
49. Koroshetz WJ. Warfarin, aspirin, and intracranial vascular disease. N Engl J Med 2005; 352:1368-1370. (Pubitemid 40411504)
50. Wong KS, Chen C, Ng PW, et al. Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study. Lancet Neurol 2007; 6:407-413. (Pubitemid 46551851)
51. Chaturvedi S, Turan TN, Lynn MJ, et al. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology 2007; 69:2063-2068. (Pubitemid 350175708)
52. Turan TN, Cotsonis G, Lynn MJ, et al. Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation 2007; 115:2969-2975. (Pubitemid 46912100)
53. The EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. N Engl J Med 1985; 313:1191-1200.
54. Marks MP, Wojak JC, Al-Ali F, et al. Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke 2006; 37:1016-1020.
55. Derdeyn CP, Chimowitz MI. Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial. Neuroimag Clin N Am 2007; 17:355-363. (Pubitemid 47362743)
56. Siddiq F, Memon MZ, Vazquez G, et al. Comparison between primary angioplasty and stent placement for symptomatic intracranial atherosclerotic disease: meta-analysis of case series. Neurosurgery 2009; 65:1024-1033.
57. SSYLVIA SI. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004; 35:1388-1392.
58. Groschel K, Schnaudigel S, Pilgram SM, et al. A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke 2009; 40:340-347.
59. Jiang W-J, Cheng-Ching E, Abou-Chebl A, et al. Multi-Center Analysis of Stenting in Symptomatic Intracranial Atherosclerosis. Neurosurgery 2011. [Epub ahead of print]
60. Suh DC, Kim JK, Choi JW, et al. Intracranial stenting of severe symptomatic intracranial stenosis: results of 100 consecutive patients. AJNR Am J Neuroradiol 2008; 29:781-785. (Pubitemid 351596115)
61. Jiang WJ, Srivastava T, Gao F, et al. Perforator stroke after elective stenting of symptomatic intracranial stenosis. Neurology 2006; 66:1868-1872. (Pubitemid 44049818)
62. Fiorella D, Woo HH. Emerging endovascular therapies for symptomatic intracranial atherosclerotic disease. Stroke 2007; 38:2391-2396. (Pubitemid 47457590)
63. Fields JD, Petersen BD, Lutsep HL, et al. Drug eluting stents for symptomatic intracranial and vertebral artery stenosis. Interv Neuroradiol 2011; 17:241-247.
64. Bose A, Hartmann M, Henkes H, et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 2007; 38:1531-1537. (Pubitemid 46684170)
65. Fiorella D, Levy EI, Turk AS, et al. US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007; 38:881-887. (Pubitemid 46568447)
66. Fiorella DJ, Turk AS, Levy EI, et al. U.S. Wingspan Registry: 12-month followup results. Stroke 2011; 42:1976-1981.
67. Levy EI, Turk AS, Albuquerque FC, et al. Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery 2007; 61:644-650. (Pubitemid 47442683)
68. Zaidat OO, Klucznik R, Alexander MJ, et al. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology 2008; 70:1518-1524. (Pubitemid 351589505)
69. Jiang WJ, Yu W, Du B, et al. Outcome of patients with 70% symptomatic intracranial stenosis after wingspan stenting. Stroke 2011; 42:1971-1975.
70. Fiorella DJ, Turk AS, Levy EI, et al. U.S. Wingspan Registry: 12-month followup results. Stroke 2011; 42:1976-1981.
71. Meyers PM, Schumacher HC, Higashida RT, et al. Indications for the performance of intracranial endovascular neurointerventional procedures: a scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation 2009; 119:2235-2249.
72. Nahab F, Lynn MJ, Kasner SE, et al. Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology 2009; 72:2014-2019.